Kronox Lab IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Kronox Lab

CMP

153.50

-3.44 (-2.19%)

  • DRHP
₹136

Offer Price

₹ 130.15 Cr

Issue Size

₹ 14,960

Min Investment

118.22x

Times Subscribed

110

Lot size

Time Line

  • 03
    Jun 2024
    Open
  • 05
    Jun 2024
    Close
  • 06
    Jun 2024
    Finalisation of Basis of Allotment
  • 07
    Jun 2024
    Initiation of Refunds
  • 07
    Jun 2024
    Transfer of Shares to Demat Account
  • 10
    Jun 2024
    Listing Date

Shares Offered

Number of Times Subscribed

Objects of the Offer

  • Expand its product portfolio, increasing the supply of its products to its existing customers and tap new customers in existing and new geographies.

  • Expand its capacity for existing products and diversifying into new products by setting up a new manufacturing facility.

  • Explore newer applications for its existing products and developing new products that are in synergy with its current and future operations.

  • Focus on import substitution and increasing exports.

  • Improve cost management and operational efficiencies.

Products & Services

  • Kronox Lab Sciences Limited manufactures High Purity Speciality Fine Chemicals for diversified end user industries.

Strengths

  • Wide range of products finding applications in diversified end user industries.

  • Long standing relationships with customers.

  • High entry and exit barriers due to long customer approval cycles and strict product standards.

  • Focus on R&D and Quality Control.

  • Zero debt company with strong and consistent financial performance.

Risks

  • The company`s products are required to meet domestic and international industry standards. In the event of any deviation from these standards, its products may faces rejection from its customers, which may affect the reputation of the Company.

  • If the company fails to execute its strategy to expand its business or the company`s production capacity, its business and prospects may be materially and adversely affected.

  • Its products are supplied in limited quantities for specific use by application industries. Any reduction in the requirement of its products may result in loss of business and may affect its financial performance and condition.

  • Its top 20 products contributed 60.49%, 70.58%, 68.62%, 69.85% and 70.04% of its revenue for the nine months period ended December 31, 2023, December 31, 2022 and the Fiscal 2023, Fiscal 2022 and Fiscal 2021, respectively. Any change in demand its products of those products could significantly affect its revenues.

  • The majority of sale of its products is concentrated in industries viz. Pharmaceuticals and Scientific Research and Laboratory Testing. Any change in demand or change in application or processes by its customers in these industries may lead to loss of revenues and profits.

Company Promoters

Promoters Holding

Issue For IPO
99.98%
Pre Holding

99.98%

Post Holding

-

Top Promoters Holding

Financials

All values in Cr

Mar-2021 Mar-2022 Mar-2023 3-Yr trend
Revenue 62.46 (-) 82.25 (31.70%) 95.58 (16.20%)
Gross Profit 62.46 (-) 82.25 (31.70%) 95.58 (16.20%)
Net Income 62.46 (-) 82.25 (31.70%) 95.58 (16.20%)
Assets 62.46 (-) 82.25 (31.70%) 95.58 (16.20%)
Liabilities 62.46 (-) 82.25 (31.70%) 95.58 (16.20%)

Book Running Managers

  • Pantomath Capital Advisors Pvt Ltd

Registrar & Transfer Agent

KFin Techologies Ltd

Karvy Selenium Tow-B,
31&32 Financial Dist,
Nanakramguda - Hyderabad-500032
Phone : 91-40-67162222 Fax: 91-40-23001153/23420814

Company Contact Information

Block # 353 Village Ekalbara,
Padra,
Vadodara - 391440
Phone : +91 26 6224 4077/88 Email : cs@kronoxlabsciences.com www.kronoxlabsciences.com

Offer Related Information

Initial public offering of 95,70,000* equity shares of face value of Rs. 10 each ("Equity Shares") of Kronox Lab Sciences Limited ("The Company" or "Issuer") for cash at a price of Rs. 136 per equity share (including a premium of Rs. 126 per equity share) ("Offer Price") aggregating to Rs. 130.15 crores ("Offer"). The offer comprises an offer for sale of 31,90,000* equity shares aggregating to Rs. 43.38 crores by Jogindersingh Jaswal, 31,90,000* equity shares aggregating to Rs. 43.38 crores... More

News

  • No Data Found.

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: